• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大在治疗重度抑郁症方面取得的进展。

Progress against major depression in Canada.

作者信息

Patten Scott B

机构信息

Alberta Heritage Foundation for Medical Research, Department of Community Health Sciences, Department of Psychiatry, University of Calgary, Calgary, Alberta.

出版信息

Can J Psychiatry. 2002 Oct;47(8):775-80. doi: 10.1177/070674370204700810.

DOI:10.1177/070674370204700810
PMID:12420657
Abstract

BACKGROUND

Generally, public health strategies for major depression have focused on case-finding, public and professional education, and disease-management strategies. In principle, increased rates of treatment utilization and improved treatment outcomes should lead to improved mental health at the population level. Progress of this sort, however, has been difficult to confirm.

METHODS

The National Population Health Survey (NPHS) is a large-scale longitudinal study of a representative sample drawn from the Canadian population. To date, Statistics Canada has released data from 3 NPHS cycles: 1994-1995, 1996-1997, and 1998-1999. Treatment utilization and major depression measures were employed in the NPHS survey, providing a unique source of longitudinal Canadian data. In this study, major depression point prevalence (defined using a predictive instrument for annual major depressive episode [MDE] prevalence and responses from a distress scale) and associated treatment utilization were evaluated over time.

RESULTS

Between 1994-1995 and 1995-1996, the proportion of persons with depression receiving antidepressant treatment increased dramatically, from 18.2% (12.3% to 22.1%) in 1994-1995 to 32.6% (23.0% to 42.2%) in 1998-1999. Point prevalence of major depression was 2.4%, 1.8%, and 1.9% in the 3 NPHS iterations.

CONCLUSIONS

Data from the NPHS suggest public health progress against major depression in Canada. More people with major depression in Canada are receiving treatment, and these changes may have been associated with improved population health status. However, both random variation and extraneous societal factors could account for the observed trends in prevalence. It is impossible to relate changes in utilization directly to population health status using the NPHS data.

摘要

背景

一般而言,针对重度抑郁症的公共卫生策略主要集中在病例发现、公众和专业教育以及疾病管理策略上。原则上,治疗利用率的提高和治疗效果的改善应能在人群层面改善心理健康状况。然而,此类进展难以得到证实。

方法

全国人口健康调查(NPHS)是一项对从加拿大人口中抽取的具有代表性样本进行的大规模纵向研究。迄今为止,加拿大统计局已发布了3个NPHS周期的数据:1994 - 1995年、1996 - 1997年和1998 - 1999年。NPHS调查采用了治疗利用率和重度抑郁症测量方法,提供了加拿大纵向数据的独特来源。在本研究中,对重度抑郁症的点患病率(使用年度重度抑郁发作[MDE]患病率预测工具和痛苦量表的反应来定义)及相关治疗利用率随时间进行了评估。

结果

在1994 - 1995年至1998 - 1999年期间,接受抗抑郁治疗的抑郁症患者比例大幅上升,从1994 - 1995年的18.2%(12.3%至22.1%)增至1998 - 1999年的32.6%(23.0%至42.2%)。在3个NPHS周期中,重度抑郁症的点患病率分别为2.4%、1.8%和1.9%。

结论

NPHS的数据表明加拿大在防治重度抑郁症方面取得了公共卫生进展。加拿大有更多的重度抑郁症患者正在接受治疗,这些变化可能与人群健康状况的改善有关。然而,随机变异和外部社会因素都可能解释所观察到的患病率趋势。使用NPHS数据无法直接将利用率的变化与人群健康状况联系起来。

相似文献

1
Progress against major depression in Canada.加拿大在治疗重度抑郁症方面取得的进展。
Can J Psychiatry. 2002 Oct;47(8):775-80. doi: 10.1177/070674370204700810.
2
Major depression and mental health care utilization in Canada: 1994 to 2000.加拿大的重度抑郁症与精神卫生保健利用情况:1994年至2000年
Can J Psychiatry. 2004 May;49(5):303-9. doi: 10.1177/070674370404900505.
3
Rural-urban differences in the prevalence of major depression and associated impairment.重度抑郁症患病率及相关损害的城乡差异。
Soc Psychiatry Psychiatr Epidemiol. 2004 Jan;39(1):19-25. doi: 10.1007/s00127-004-0698-8.
4
A framework for describing the impact of antidepressant medications on population health status.
Pharmacoepidemiol Drug Saf. 2002 Oct-Nov;11(7):549-59. doi: 10.1002/pds.746.
5
The utilization of antidepressants and benzodiazepines among people with major depression in Canada.加拿大重性抑郁障碍患者中抗抑郁药和苯二氮䓬类药物的使用情况。
Can J Psychiatry. 2011 Nov;56(11):667-76. doi: 10.1177/070674371105601105.
6
Antidepressant utilization in Canada.加拿大的抗抑郁药使用情况。
Soc Psychiatry Psychiatr Epidemiol. 2005 Oct;40(10):799-807. doi: 10.1007/s00127-005-0968-0.
7
Weight gain in relation to major depression and antidepressant medication use.体重增加与重度抑郁症和抗抑郁药物使用的关系。
J Affect Disord. 2011 Nov;134(1-3):288-93. doi: 10.1016/j.jad.2011.06.027. Epub 2011 Jul 19.
8
[Use of services and treatment adequacy of major depressive episodes in France].[法国重度抑郁发作的服务利用情况与治疗充分性]
Encephale. 2010 Jun;36 Suppl 2:D48-58. doi: 10.1016/j.encep.2008.10.011. Epub 2009 Jun 10.
9
The difference between single and married mothers in the 12-month prevalence of major depressive syndrome, associated factors and mental health service utilization.单身母亲与已婚母亲在重度抑郁综合征12个月患病率、相关因素及心理健康服务利用方面的差异。
Soc Psychiatry Psychiatr Epidemiol. 2004 Jan;39(1):26-32. doi: 10.1007/s00127-004-0699-7.
10
The duration of major depressive episodes in the Canadian general population.加拿大普通人群中重度抑郁发作的持续时间。
Chronic Dis Can. 2001;22(1):6-11.

引用本文的文献

1
Descriptive epidemiology of major depressive disorder in Canada in 2012.2012年加拿大重度抑郁症的描述性流行病学研究。
Can J Psychiatry. 2015 Jan;60(1):23-30. doi: 10.1177/070674371506000106.
2
The wisdom of crowds (vox populi) and antidepressant use.群体智慧(民众的意见)与抗抑郁药物的使用。
Clin Pract Epidemiol Ment Health. 2015 Jan 30;11:1-3. doi: 10.2174/1745017901510011001. eCollection 2015.
3
Prevalence and risk factors of depressive symptoms in a Canadian palliative home care population: a cross-sectional study.
在加拿大姑息治疗家庭护理人群中,抑郁症状的流行情况和风险因素:一项横断面研究。
BMC Palliat Care. 2014 Mar 17;13(1):10. doi: 10.1186/1472-684X-13-10.
4
Does it matter what you measure? Neighbourhood effects in a canadian setting.测量的内容重要吗?加拿大环境中的邻里效应。
Healthc Policy. 2010 Aug;6(1):47-63.
5
Relation between depression and sociodemographic factors.抑郁与社会人口学因素的关系。
Int J Ment Health Syst. 2007 Sep 4;1(1):4. doi: 10.1186/1752-4458-1-4.